Gene Editing Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease Posted on May 3, 2022 by Editorial Staff Researchers demonstrated that plasma levels of leucine-rich repeat-containing 15 are a strong indicator of the severity of COVID-19 in patients with end-stage kidney disease. Share on FacebookTweetFollow us Editorial Staff STAT+: A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO Study explores SARS-CoV-2 RNA genome’s functional interactions with host cell